Table 1 Patient demographics, diagnoses, and CYP2D6/CYP2C19 phenotypes.
Characteristics | Â |
|---|---|
Age (median, range) | 30 (0.5–98) |
Gender | N (%) |
  Male | 5296 (35%) |
  Female | 9493 (63%) |
  Not Stated | 211 (2%) |
Imputed race/ethnicity | |
  White | 12,250 (82%) |
  Hispanic/Latino | 1077 (7%) |
  Black | 964 (6%) |
  Complex | 371 (2%) |
  Asian | 338 (2%) |
Diagnosis | |
  MDD | 6659 (44%) |
  GAD | 5708 (38%) |
  ADHD | 2878 (19%) |
  BPD | 1231 (10%) |
  PTSD | 1103 (8%) |
  SCZ | 79 (<1%) |
CYP2C19 Metabolizer Phenotypes | |
  Poor | 420 (3%) |
  Intermediate | 3998 (27%) |
  Normal | 6041 (40%) |
  Rapid | 3573 (24%) |
  Ultrarapid | 995 (7%) |
CYP2D6 Metabolizer Phenotypes | |
  Poor | 873 (6%) |
  Intermediate | 5849 (39%) |
  Normal | 7770 (52%) |
  Ultrarapid | 508 (3%) |
